Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of C-reactive protein as a prognostic marker in COVID-19
Dominic Stringer, Philip Braude, Phyo Kyaw Myint, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 2, pp. 420-429
Open Access | Times Cited: 177

Showing 1-25 of 177 citing articles:

Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study
Renin Chang, Thomas Yen‐Ting Chen, Shiow‐Ing Wang, et al.
EClinicalMedicine (2023) Vol. 56, pp. 101783-101783
Open Access | Times Cited: 203
Fatigue and cognitive impairment after COVID-19: A prospective multicentre study
Tim J. Hartung, Christian Neumann, Thomas Bahmer, et al.
EClinicalMedicine (2022) Vol. 53, pp. 101651-101651
Open Access | Times Cited: 135
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Decoding clinical biomarker space of COVID-19: Exploring matrix factorization-based feature selection methods
Farshad Saberi-Movahed, Mahyar Mohammadifard, Adel Mehrpooya, et al.
Computers in Biology and Medicine (2022) Vol. 146, pp. 105426-105426
Open Access | Times Cited: 63
Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis
Bartosz Fialek, Michał Pruc, Jacek Smereka, et al.
Cardiology Journal (2022) Vol. 29, Iss. 5, pp. 751-758
Open Access | Times Cited: 52
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial
Carlo Salvarani, Marco Massari, Massimo Costantini, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 4, pp. 2200025-2200025
Open Access | Times Cited: 46
Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial
Aaron M. Gusdon, Nauder Faraday, John S. Aita, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 654
Closed Access | Times Cited: 45
Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)
Carlos Tornero, Ernesto Pastor Díaz de Garayo, María del Mar Garzando, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 40
The roles of C-reactive protein-albumin ratio as a novel prognostic biomarker in heart failure patients: A systematic review
Roy Bagus Kurniawan, Pratista Oktafia, Pandit Bagus Tri Saputra, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 5, pp. 102475-102475
Open Access | Times Cited: 7
The role of C-reactive protein in predicting the severity of COVID-19 disease: A systematic review
Getachew Yideg Yitbarek, Gashaw Walle Ayehu, Sintayehu Asnakew, et al.
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 53
Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study
Niklas Broman, Thijs Feuth, Tytti Vuorinen, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 6, pp. 844-851
Open Access | Times Cited: 30
Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval
Aidan M. Kirkham, Adrian Bailey, Madeline Monaghan, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 7, pp. 675-687
Open Access | Times Cited: 28
Oxidative Stress and Lipid Profile During Acute Phase of COVID-19 Infection and After Recovery: Evidence of a Sequel in LDL
Zahra Lotfollahi, Luana dos S. Neres, Andressa F. Mathias, et al.
Brazilian Journal of Physics (2025) Vol. 55, Iss. 2
Closed Access
Prognostic significance of cytokine dysregulation in critically ill COVID-19 patients
Fabian Fellipe Bueno Lemos, Luana Weber Lopes, Giselle de Carvalho Brito, et al.
Cytokine (2025) Vol. 187, pp. 156867-156867
Closed Access
The Linear Association of Chest Radiograph Opacification With Both Respiratory Physiology and Systemic Inflammation in Hospital In‐Patients With Covid‐19 Infection
Colin Crooks, Dominick Shaw, Tim Card, et al.
The Clinical Respiratory Journal (2025) Vol. 19, Iss. 2
Open Access
Utilising routinely collected clinical data through time series deep learning to improve identification of bacterial bloodstream infections: a retrospective cohort study
Damien Ming, Vasin Vasikasin, Timothy M. Rawson, et al.
The Lancet Digital Health (2025) Vol. 7, Iss. 3, pp. e205-e215
Open Access
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein
Manuela Rizzi, Martina Costanzo, Stelvio Tonello, et al.
Disease Markers (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 25
COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters
Manuela Rizzi, Davide D’Onghia, Stelvio Tonello, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7099-7099
Open Access | Times Cited: 14
Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
Katrin Hufnagel, Anahita Fathi, Nadine Stroh, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 13
The death rate of COVID-19 infection in different SARS-CoV-2 variants was related to C-reactive protein gene polymorphisms
Sahar Sadeghi Mofrad, Shayan Boozarjomehri Amnieh, Mohammad Reza Pakzad, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
C-reactive protein levels associated with COVID-19 outcomes in the United States
Jacob Lentner, Taylor Adams, Valene Knutson, et al.
Journal of Osteopathic Medicine (2021) Vol. 121, Iss. 12, pp. 869-873
Closed Access | Times Cited: 31
Predictors of severity and mortality in COVID-19 patients
Hebatallah Hany Assal, Hoda M. Abdel-Hamid, Sally Magdy, et al.
Egyptian Journal of Bronchology (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 20
The naturally‐derived alkaloids as a potential treatment for COVID‐19: A scoping review
Bárbara Longhini Gonzalez, Natalia Castelhano de Oliveira, Mariane Roberta Ritter, et al.
Phytotherapy Research (2022) Vol. 36, Iss. 7, pp. 2686-2709
Open Access | Times Cited: 20
Role of C-Reactive Protein in Kidney Diseases
Jiaxiao Li, Junzhe Chen, Hui Y. Lan, et al.
Kidney Diseases (2022) Vol. 9, Iss. 2, pp. 73-81
Open Access | Times Cited: 18
An Overview of the Impact of Bacterial Infections and the Associated Mortality Predictors in Patients with COVID-19 Admitted to a Tertiary Center from Eastern Europe
Amalia-Stefana Timpau, Radu-Ștefan Miftode, Irina‐Iuliana Costache, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 144-144
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top